Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhouliang Wu
Observed name:
Wu, Zhouliang
Institutions:
Second Hospital of Tianjin Medical University,
Tianjin Medical University
Observed institutions:
Second Hospital of Tianjin Medical University,
Tianjin Medical University
OpenAlex ID:
A5153083375
In vivo programming of dual-targeted CAR-T cells facilitates vascular disruption and T-cell infiltration in solid tumors
2026
·
Mengyao Li
, Zefang Lu
, et al.
·
Nature Communications
PDF
Disitamab Vedotin Plus Tislelizumab in Transurethrally Unresectable, ERBB2 -Positive, Non–Muscle-Invasive Bladder Cancer: A Nonrandomized Clinical Trial
2026
·
Yunkai Qie
, Kaipeng Jia
, et al.
·
JAMA Oncology
PDF
Isocyanate‐Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3‐Mediated Extracellular Matrix Remodeling and cGAS‐STING Pathway Activation in Bladder Cancer
2026
·
Linhui Wang
, Xiaomeng Liu
, et al.
·
Advanced Science
Show more works
View as search
Works count:
10
Citation count:
H-index:
I10-index:
Year
Topic
Type